4.4 Article

Comparing costs of standard Breast-Conserving Surgery to Oncoplastic Breast-Conserving Surgery and Mastectomy with Immediate two-stage Implant-Based Breast Reconstruction

期刊

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.bjps.2022.02.050

关键词

Breast Cancer; Breast-Conserving Surgery; Oncoplastic Breast-Conserving Surgery; Breast Reconstruction; Costs; Complications

类别

向作者/读者索取更多资源

This study compared the costs and complication rates of conventional breast-conserving surgery (C-BCS), oncoplastic breast-conserving surgery (OP-BCS), and mastectomy with immediate two-stage implant-based breast reconstruction (M-IBR). The results showed that OP-BCS was financially non-inferior to M-IBR in terms of total treatment costs, but M-IBR had higher complication rates.
Background: Conventional breast-conserving surgery (C-BCS) has equal oncologi-cal outcomes and superior cosmetic and patient-reported outcomes compared to mastectomy with immediate two-stage implant-based breast reconstruction (M-IBR). Oncoplastic breast -conserving surgery (OP-BCS) is increasingly being used, as it often has better cosmetic results and it enables larger tumour resection. However, OP-BCS and M-IBR compared to C-BCS length-ens operative time and might lead to more complications and consequently to additional costs. Therefore, this study aimed to compare costs and complication rates of C-BCS, OP-BCS and M-IBR.Methods: This single-centre, retrospective cohort study, calculated costs for all patients who had undergone breast cancer surgery between January 2014 and December 2016. Patient-, tumour-and surgery-related data of C-BCS, OP-BCS and M-IBR patients were retrieved by med-ical record review. Treatment costs were calculated using hospital financial data. Differences in costs and complications were analysed.Results: A total of 220 patients were included: 74 patients in the C-BCS, 78 in the OP-BCS and 68 in the M-IBR group. From most expensive to least expensive, differences in total costs were found between C-BCS vs. OP-BCS and C-BCS vs. M-IBR (p = < 0.01 and p = 0.04, respectively). Costs of OP-BCS and M-IBR were comparable. Complication rates were 5.5% for C-BCS, followed by 17% for OP-BCS, and 34% for M-IBR (p < 0.01).Conclusion: Considering total treatment costs, OP-BCS was financially non-inferior to M-IBR, whereas complication rates were higher following M-IBR. Therefore, when considering other benefits of OP-BCS, such as higher patient-reported outcomes and similar oncological out-comes, a shift from M-IBR to BCS using oncoplastic techniques seems justified.(c) 2022 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by El-sevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据